| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
10,639 |
9,998 |
$1.95M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
5,253 |
4,980 |
$1.19M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
852 |
828 |
$565K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,234 |
1,184 |
$461K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
436 |
425 |
$217K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,179 |
2,073 |
$202K |
| 70450 |
Computed tomography, head or brain; without contrast material |
493 |
483 |
$90K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
27 |
26 |
$8K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
27 |
26 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,588 |
1,506 |
$811.52 |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
26 |
26 |
$779.72 |
| 73130 |
|
274 |
265 |
$514.56 |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,721 |
1,597 |
$316.54 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
849 |
814 |
$241.50 |
| 80053 |
Comprehensive metabolic panel |
3,760 |
3,491 |
$202.64 |
| 81025 |
|
2,517 |
2,401 |
$195.77 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,543 |
2,391 |
$176.18 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
958 |
930 |
$153.28 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
69 |
68 |
$137.61 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,905 |
3,687 |
$133.18 |
| 71045 |
Radiologic examination, chest; single view |
1,484 |
1,429 |
$116.93 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,649 |
1,607 |
$109.61 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
311 |
307 |
$95.29 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
315 |
310 |
$95.19 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,142 |
1,102 |
$81.56 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
639 |
471 |
$67.12 |
| 87631 |
|
1,147 |
1,121 |
$61.07 |
| 73630 |
|
335 |
328 |
$58.06 |
| 71046 |
Radiologic examination, chest; 2 views |
1,095 |
1,052 |
$54.95 |
| 81003 |
|
2,655 |
2,522 |
$53.78 |
| 82803 |
|
187 |
174 |
$37.45 |
| 73610 |
|
139 |
135 |
$36.06 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
136 |
127 |
$30.54 |
| 84702 |
|
310 |
299 |
$26.48 |
| 83605 |
|
204 |
186 |
$20.27 |
| 84484 |
|
852 |
809 |
$18.60 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,298 |
2,148 |
$14.89 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
13 |
13 |
$10.35 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
432 |
423 |
$5.65 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
17 |
14 |
$5.39 |
| 82962 |
|
101 |
95 |
$5.36 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,586 |
1,479 |
$4.75 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,297 |
2,170 |
$2.17 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
209 |
197 |
$0.75 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,092 |
1,058 |
$0.24 |
| 82565 |
|
54 |
53 |
$0.00 |
| 82947 |
|
54 |
53 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
380 |
354 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
550 |
508 |
$0.00 |
| 90715 |
|
66 |
66 |
$0.00 |
| 74018 |
|
53 |
52 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
17 |
16 |
$0.00 |
| 87634 |
|
182 |
177 |
$0.00 |
| 73562 |
|
39 |
38 |
$0.00 |
| 84520 |
|
54 |
53 |
$0.00 |
| 87186 |
|
13 |
13 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$0.00 |
| 73030 |
|
13 |
12 |
$0.00 |
| 80076 |
|
15 |
14 |
$0.00 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
14 |
12 |
$0.00 |
| 80306 |
|
13 |
13 |
$0.00 |
| 82550 |
|
89 |
88 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
379 |
374 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
723 |
674 |
$0.00 |
| 96376 |
|
40 |
37 |
$0.00 |
| J3490 |
Unclassified drugs |
950 |
896 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
155 |
150 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
3,933 |
3,731 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
496 |
479 |
$0.00 |
| 80051 |
|
89 |
88 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
70 |
70 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,197 |
1,161 |
$0.00 |
| 82553 |
|
353 |
318 |
$0.00 |
| 87428 |
|
58 |
58 |
$0.00 |
| 76830 |
Ultrasound, transvaginal |
12 |
12 |
$0.00 |
| 93971 |
|
24 |
24 |
$0.00 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
55 |
53 |
$0.00 |
| 85379 |
|
237 |
231 |
$0.00 |
| 87077 |
|
15 |
15 |
$0.00 |